Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
PALI-2108 is orally delivered and colon-specific allowing for local activity with low systemic exposure Company on track to commence Phase...
COVID-19
Medical Virtual Assistant Market Size to Grow USD 2668.4 Million by 2029 at a CAGR of 27.9% | Valuates Reports
BANGALORE, India, June 10, 2024 /PRNewswire/ -- Medical Virtual Assistant Market is Segmented by Type (Virtual Health Coaches, Virtual Health...
Drug Discovery Informatics Market Size to Grow USD 1 Million by 2030 at a CAGR of 9% | Valuates Reports
BANGALORE, India, June 10, 2024 /PRNewswire/ -- Drug Discovery Informatics Market is Segmented by Type (Software, Services), by Application (Pharmaceutical & Biotechnology Companies,...
Cell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report by InsightAce Analytic
JERSEY CITY, N.J., June 10, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report...
FSi Partners with Microsoft and the White House to Support Rural Healthcare Cybersecurity
VIENNA, Va., June 10, 2024 /PRNewswire/ -- FSi Strategies, a leading Microsoft managed IT service provider, announced today that it...
IQAir Introduces New XE Smart Air Purifiers
STEINACH, Switzerland, June 10, 2024 /PRNewswire/ -- IQAir, a Swiss air quality technology company, launches their new XE air purifiers,...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
mRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines...
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
Live video webcast on Monday, June 17th at 1:00 PM ETOCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech...
Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 10, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending...
Klick Health Adds 18 Senior Leaders as 27-Year Double-Digit Growth Spurt Continues
Independent health agency continues to attract industry’s brightest minds; fortifies teams companywide as part of commitment to delivering industry-leading innovation,...
Combined General Meeting of June 24, 2024
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 7, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the...
Ada Health, The Most Accurate AI for Care Navigation, Expands Its Leadership Team for Strategic Growth with Product and Business Development Hires
The AI-powered symptom assessment and care navigation platform, which gives 50M+ users access to its enterprise solutions, reaches key growth...
Moderna’s Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program
Center for Biologics Evaluation and Research has chosen mRNA-3705 as one of four investigational medicines for accelerated development to address...
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
New research data confirms superiority of TRUFORMA's Bulk Acoustic Wave Sensor technology in diagnosing feline hyperthyroidism ANN ARBOR, MI /...
Telehealth System Featuring Rokid Glass 2 Wins HHS Award
HANGZHOU, China, June 5, 2024 /PRNewswire/ -- Rokid's augmented reality (AR) devices are making significant inroads into the medical sector. Utilizing...
Masimo Joins Forces with the Mobilize Recovery 2024 Bus Tour
Collaborative Partnership Designed to Enhance Nationwide Efforts to Combat the Opioid Epidemic and Improve Addiction RecoveryIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI),...
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
DNA vaccine proof-of-concept study expected to demonstrate an “mRNA better” platform LAWRENCEVILLE, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- IMUNON,...
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
FDA review of historic data shows patients who received robotic prostatectomies have overall cancer survival rates on par with open...
Theralase(R) Technology Effective in Virus Inactivation
TORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...